BiomX Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for PHGE, updated each market day.
PHGE AI Sentiment
AI predicts BiomX Inc. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About BiomX Inc.
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
Sector
Exchange
Market Cap
$19,565,112
Cap Tier
Employees
57
Headquarters
DOVER, DE
Listed Since
March 13, 2019
Website
PHGE Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PHGE Volatility
BiomX Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
